Question 63

Rabeprazole and aripiprazole are included on the list of look-alike/sound-alike medications maintained by the Institute for Safe Medication Practices (ISMP).

This pair is recognized by the ISMP as having similar appearances or pronunciations that could lead to medication errors, making it critical for healthcare providers to be aware of these similarities.

A) Rabeprazole and aripiprazole

This option is correct as it identifies a pair of medications that the ISMP has specifically listed due to their potential for confusion. Both medications have similar-sounding names, which can lead to prescribing or dispensing errors if not properly distinguished.

B) Prednisolone and risperidone

This option is incorrect as these two medications, while they may have some similar syllables, are not included on the ISMP list. The differences in their indications and classifications reduce the likelihood of confusion in clinical settings.

C) Nicardipine and naloxone

This option is also incorrect. Although both medications are used in critical care settings, they are not listed by the ISMP as look-alike/sound-alike medications. Their distinct therapeutic uses further minimize the risk of mix-up.

D) Amlodipine and alprazolam

This choice is incorrect as well. While these medications may be confused due to their similar beginnings, they do not appear on the ISMP list. Their different classes and indications help healthcare professionals differentiate between them effectively.

Conclusion

The pair of rabeprazole and aripiprazole is correctly identified as a look-alike/sound-alike medication duo, which underscores the importance of vigilance in medication management to prevent errors. The other options, while they may have similarities, are not recognized by the ISMP, demonstrating the specific nature of the list and the need for awareness of these potential pitfalls in medication safety.